• 1

  • Weak interest from European and other international partners for cooperation with R&D institutions from RS in the field of advanced medical research – as this is the case with other field, R&D sector is not interesting for cooperation with a certain number of international partners, due to low competitiveness and technological obsolescence.  
  • In the framework of existing strategies and policies there is no precise identification of the action plans for improvement of the existing public health infrastructure nor of possible funding sources.
  • Possible decrease of allocations for modern RTD infrastructure due to the global financial crisis. Even the recent changes in legislation have predicted increase of allocations for RTD sector yearly with final goal of 1% of GDP, the practice shows that due to financial obstacles and budgetary deficit this is not realized in practice.
  • Regional (RS) RTD program priorities far too general not providing action plans for improvement of RTD activities - the definition of programme priorities in RS is done mainly according to their own needs without previous harmonization with European and regional program aims. The subjects defined in R&D papers are defined in the “bottom up” approach for publicly funded programmes. There is no regional priority where the respective ministry will undertake “top-down” approach for identification of programme priorities.
  • No serious attempts in the establishment of bilateral and multilateral functional mechanisms for researcher's mobility based on reciprocity principle of which healthcare institutions would benefit.

Events Calendar

October 2017
Mon Tue Wed Thu Fri Sat Sun
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31